ACTIVE_NOT_RECRUITING

Immunogenicity of HPV Vaccine in Transplant Recipients.

Talk to us

Conditions

Chronic Kidney DiseasesKidney Transplant

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.

Official Title

Prospective Analysis of Immunogenicity of the Nonavalent Human Papillomavirus Vaccination (GARDASIL 9) in Patients Post Solid Organ Transplant

Quick Facts

Study Start:2023-06-01
Study Completion:2035-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05557370

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patient between the age of 18 and 45 years
  2. 2. Patient is at least 6 months post-solid-organ transplant and has not received GARDASIL 9.
  3. 3. Patient who can participate in their health care and sign informed consent.
  4. 4. Patient may have had bivalent or quadrivalent HPV vaccination previously.
  5. 5. Living or deceased donor transplant patient is eligible.
  1. 6. Contraindication: Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL.
  2. 7. Patient had completed vaccination series with a nonavalent HPV vaccine (e.g., GARDASIL 9) in the past
  3. 8. Patient with a diagnosis of HIV.
  4. 9. Patient that endorses being currently pregnant.

Contacts and Locations

Principal Investigator

Denise Uyar, MD
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin/ Froedtert Hospital

Study Locations (Sites)

Froedtert Lutheran Memorial Hospital
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

  • Denise Uyar, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin/ Froedtert Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-01
Study Completion Date2035-12-31

Study Record Updates

Study Start Date2023-06-01
Study Completion Date2035-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Kidney Diseases
  • Kidney Transplant